MURDER, POLITICS, AND THE END OF THE JAZZ AGE
by Michael Wolraich
Order today at Barnes & Noble / Amazon / Books-A-Million / Bookshop
MURDER, POLITICS, AND THE END OF THE JAZZ AGE by Michael Wolraich Order today at Barnes & Noble / Amazon / Books-A-Million / Bookshop |
By John D. Abramson, (a lecturer at Harvard Medical School and the author of “Overdosed America: The Broken Promise of American Medicine,” serves as an expert in litigation involving the pharmaceutical industry,) and Rita F. Redberg (a cardiologist at the University of California, San Francisco Medical Center and the editor of JAMA Internal Medicine.)
New York Times Guest op-ed, Nov. 13/14, 2013
ON Tuesday, the American Heart Association and the American College of Cardiology issued new cholesterol guidelines that essentially declared, in one fell swoop, that millions of healthy Americans should immediately start taking pills — namely statins — for undefined health “benefits.”
This announcement is not a result of a sudden epidemic of heart disease, nor is it based on new data showing the benefits of lower cholesterol. Instead, it is a consequence of simply expanding the definition of who should take the drugs — a decision that will benefit the pharmaceutical industry more than anyone else [....]
Comments
by artappraiser on Sat, 11/16/2013 - 7:47pm
Honest Abe of cardiology; my bold:
From (recommended) article:
Flawed Gauge for Cholesterol Risk Poses a New Challenge for Cardiologists
By Gina Kolata, New York Times, Nov. 19/20, 2013
Another excerpt of particular note, mho, as it's encouraging evidence of a medical professor that believes in treating patients instead of treating tests:
-----
Also see
A credibility disaster for cardiology
on rmrd0000's news thread: New Guidelines for statin use,
which includes discussion & a link to NY Times expert debate on "When Medical Experts Disagree".
by artappraiser on Sat, 11/23/2013 - 11:18pm
But do they disagree on the original guidelines as, say, a minimum?
by Peter Schwartz on Sun, 11/24/2013 - 3:32pm
They basically upended original guidelines; that's what the whole story is about! They basically said "everyone, throw out what you've been doing and how you've been thinking, this is what you should do now"! There is no agreement, there is "controversy": and "turmoil"
by artappraiser on Sun, 11/24/2013 - 4:46pm
But it sounds like the real problem is with the "sweeping NEW set of guidelines" and not with the old guidelines. So if you were prescribed under the OLD guidelines, which targeted a smaller group, you probably got a more accurate prescription.
IOW, the "embarrassing" problem seems to be in "over-estimating" the risk and making millions "more" people candidates for the drug than were candidates originally. These drugs have been out for a very long time now.
(That said, though I have a history of heart disease in my family, I resisted taking statins for a long time. I remember one doctor telling me YEARS ago, even decades ago now, that all people should take statins just as a prophylactic. I myself have never suffered serious side effects that I know of--though I know some do.)
OTOH, maybe what they're saying is that if they could make such a big mistake with the new guidelines then even the old guidelines are suspect.
I believe statins are one of those drugs whose properties were discovered accidentally. They were working with the compound to treat some other condition and discovered it lowered cholesterol. The other big benefit is protection from stroke or the worst consequences of stroke.
As you said, somewhere, they don't know why statins work. But to be fair that is true of any number of drugs. They know that a drug works, but not why. As I understand it, they don't really know why aspirin works.
I was doing some work a while back with a nursing organization, and they were talking about "evidence-based medicine" as a "new advance." This raised my eyebrows and I asked somewhat hesitatingly: "But I thought medicine was based on scientific evidence."
Apparently not in many cases. Doctors and other medical professionals do many things that haven't been rigorously tested in a scientific way. They find something that works, and they sort of pass it down from guild member to guild member. The results are reasonably good (even if something else might be much better and even if they don't know why it works), so they keep doing it.
by Peter Schwartz on Sun, 11/24/2013 - 5:40pm
There has been a relatively recent explosion in drug development. For example as recently as 1994, the choices for a diabetic was insulin and a class of drugs called sulfonylureas. There are now over ten classes of drugs that can be used to treat diabetes.some are rarely used. Once you have different groups of drugs with different applications, you can make comparisons.
A similar pharmacological explosion occurred with drugs to treat coronary artery disease and heart failure. There are also balloons and stents to treat coronary diseases and devices to treat heart failure. These new techniques allowed physicians to compare their efficacy to the previous"gold standard" therapy. Physicians applied evidence based medicine when there were alternative therapies.
Note, cancer therapy has also expanded the available treatment options as has rheumatology.
One confounding variable in some diseases is a cultural change that effects how and when diseases appears. Young people with diabetes used to present with a disease caused by an autoimmune disease where cells attacked and destroyed the cells that produced insulin. These kids were thin. Now there are young diabetics who are obese and present with a disease where more insulin is need to get glucose into cells. The disease is identical to what used to be called adult onset diabetes. The disease presentation in children has changed. Do children need the same therapy as adults or are they different?
Many people are eating more healthy and this impacts how and when coronary artery disease presents. Because of environmental/cultural changes treatment regimens will constantly change. Evidence based medicine is a moving target because the patient population is changing.
by rmrd0000 on Sun, 11/24/2013 - 7:41pm
"Medicine is a science of uncertainty and the art of probability"
-William Osler
One physician wrote an Art of Medicine article in the Lancet in 2010 about the value of uncertainty in medicine.
by rmrd0000 on Mon, 11/25/2013 - 12:43am
by artappraiser on Sat, 11/30/2013 - 9:40am
The thing about the statin guidelines is that there was immediate questioning from the medical community. The objections noted that some of the authors of the guidelines had industrial ties. The new risk calculator was also questioned since it fell out of line with prior assessments based on following actual populations over time.
The AHA/ACC Guidelines are just that, they are not laws that have to be followed under risk of penalty. I think the pushback against the guidelines from within the medical community is a good sign. Their are European counterparts to the AHA and ACC. It will interesting to see how they react to the US Guidelines. There is scientific cross- pollination between the US and Europe in that scientific papers from European and US sources are quoted in the medical literature in both places.
The Guidelines are far from being a done deal.
by rmrd0000 on Sat, 11/30/2013 - 11:05am
I think that by far the best thing about the pushback is that it is publicized so that patients know about it. That these kind of disagreements are no longer kept from the public, from those actually affected, that's the important thing. (Especially in a time when the medical-industrial complex is allowed to use marketing and advertising methods on the public and on practitioners. Not that similar problems didn't happen before that--when doctors were gods who walked the earth--but it has made such problems worse.)
by artappraiser on Sat, 11/30/2013 - 12:51pm